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Genetic reprogramming of adult somatic cells into stem 
cells, or other cell types, is a long-time dream for 
regenerative medicine. Th  e birth of Dolly, the ﬁ  rst 
reprogrammed adult cell-derived mammal, heralded a 
new era [1], yet more than a decade of research towards 
‘therapeutic cloning’ has resulted in only limited 
progress, due to many technical, ethical and legislative 
problems. Recently, genetic reprogramming of cells using 
repro  gram  ming factors in mouse and human [2] resulted 
in the production of induced pluripotent stem cells 
(iPSCs) and immediately became one of the most proliﬁ  c 
and ‘hot’ areas of biomedical research. Th   e generation of 
human iPSCs holds great promise for novel drug testing 
using patient-derived in vitro systems and the production 
of regenerative cells for tissue or organ repair, but 
without the ethical burden of the nuclear transfer 
cloning-based reprogramming methods. Nevertheless, 
the iPSC technology is still in its infancy, with numerous 
issues to be solved - a real puzzle for which many 
excellent and very competitive players are currently 
trying to ﬁ  nd the key ﬁ  tting pieces.
Colonization of the germ layer by mouse embryonic 
stem cells (‘germline transmission’) is essential for the 
production of germline competent knockout and trans-
genic mice. Recently, Han and colleagues [3] described in 
Nature that the T box gene 3 (Tbx3) [4] is amongst the 
genes that can greatly improve the quality of repro  gram-
med iPSCs and the eﬃ     cacy of germline transmission. 
T-box family genes encode transcription factors involved 
in the regulation of both embryonic and extraembryonic 
development of the embryo proper, especially as they are 
required for early cell-fate decisions, such as those 
necessary for formation of the basic vertebrate body plan 
and those involved in mesoderm formation at the early, 
inductive stage of development (mammary gland, lung, 
heart, limbs) [5]. Th   e family is characterized by a highly 
conserved sequence encoding a DNA-binding domain, 
called the T-domain, that binds speciﬁ  c sequences in the 
promoters of target genes, originally found in the 
Brachyury locus. Surprisingly, although the develop-
mental role of T-box genes is quite well described, little is 
known about how these proteins regulate their target 
genes. Th  e results obtained by Han and colleagues not 
only provide some missing pieces on the role of Tbx3 
during reprogramming but are also a step towards 
realizing ‘designer’ reprogramming strategies that require 
high quality iPSCs.
Some earlier observations that overexpression of Tbx3 
promotes LIF-independent self-renewal of stem cells [6], 
and that a parallel LIF signaling pathway might maintain 
the pluripotency of mouse stem cells, have also suggested 
that reprogramming is a complex process, and Tbx3 may 
have some speciﬁ  c roles in this process. Researchers have 
also suggested before that while Klf4 is mainly activated 
by the Jak-Stat3 pathway and signals down  stream to 
Sox2, Tbx3 is primarily regulated by the phos  phatidyl-
inositol-3-OH kinase-Akt and mitogen-activated protein 
kinase pathways and predominantly stimulates Nanog 
[7]. Importantly, in the absence of LIF, artiﬁ  cial expres-
sion of Klf4 or Tbx3 is suﬃ   cient to maintain pluripotency 
[8]. Th   ese and other observations (for example, that Tbx3 
is speciﬁ  cally expressed in precursor and progenitor cells, 
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© 2010 BioMed Central Ltdsuch as multipotent hepatic progenitor cells [9]) under-
score that Tbx3 may well participate in LIF-independent 
or parallel pathways of pluripotency/reprogramming. 
Th   ese observations give new hope for transgenic research 
and will contribute to the generation of better transgenic 
and cell-based models for studying pluripotency and cell 
fate decision-making.
At the same time the precise relationships between 
other factors - for example, Fgf10, Nrg3, Wnts and their 
relationship to Tbx3, LIF, Oct4 or Nanog - have yet to be 
fully elucidated. As applications in human medicine are 
the main goal, it is important to emphasize that 
pluripotency regulation in mouse and human diﬀ  ers in 
many details - the role of each of the above factors in 
reprogramming needs to be clariﬁ  ed in diﬀ  erent, non-
rodent model species and, most importantly, in human. 
Th  e search for molecular signatures of ‘stemness’ and 
pluripotency is only now beginning to gather momentum.
As many pieces of the ‘pluripotency regulation puzzle’ 
are still missing, the ﬁ  eld will probably supply us with 
numerous exciting publications and - after sorting out 
major issues such as stability and safety of iPSCs and 
iPSC-derived cells - hopefully with everyday medical 
applications as well. But this is still several years ahead, 
even according to the most optimistic projections - still 
plenty of time for young researchers to make an exciting 
career in the pluripotent stem cell and genetic 
reprogramming area.
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